The recent BREXIT vote in the UK threatens to disrupt scientific progress and clinical advances in the development of innovative gene and cell therapies. Leading UK researchers have called for proactive solutions to ensure continued access to critical funding and ongoing collaborative opportunities with the broader scientific community in the European Union in an editorial…